TARGETING ALPHA2DELTA-1-BOUND GLUTAMATE RECEPTORS FOR TREATING DISEASES AND DISORDERS

• 收藏
• 分享

专利权人:

The University of Texas System;Board of Regents

发明人:

Hui-lin PAN

申请号：

US16639076

公开号：

US20200181201A1

申请日:

2018.08.14

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The present disclosure provides α2δ-1 C-terminal domain mimetics for the treatment of pain, epilepsy or other disorders in a subject. Further provided is an α2δ-1 C-terminal domain peptide which blocks binding of α2δ-1 to the glutamate receptors NMDAR and AMPAR.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/